Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Hess

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Cancer|November 1, 2006
Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survivalPooja R Rohatgi, James C Yao, Kenneth Hess, et al.
Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.
Pancreas|November 27, 2014
Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumorsJames C Yao, Alexandria T Phan, Kenneth Hess, et al.
International Journal of Oncology|July 6, 2007
Activation of polyamine catabolism by N1,N11-diethylnorspermine leads to cell death in glioblastomaRongcai Jiang, Woonyoung Choi, Asad Khan, et al.
British Journal of Cancer|September 2, 2020
Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trialsJohnique T Atkins, Goldy C George, Kenneth Hess, et al.
Breast Cancer Research and Treatment|July 16, 2009
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell linesCornelia Liedtke, Jing Wang, Attila Tordai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2017
Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern eraTodd A Pezzi, Chad Tang, Cameron W Swanick, et al.
The American Journal of Surgical Pathology|May 16, 2006
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomasHoward Colman, Caterina Giannini, Li Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer DrugsDiogo D G Bugano, Kenneth Hess, Denis L F Jardim, et al.
British Journal of Cancer|September 23, 2015
Clinical nomogram to predict bone-only metastasis in patients with early breast carcinomaYann Delpech, Sami I Bashour, Ruben Lousquy, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Cancer|November 1, 2006
Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survivalPooja R Rohatgi, James C Yao, Kenneth Hess, et al.
Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.
Pancreas|November 27, 2014
Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumorsJames C Yao, Alexandria T Phan, Kenneth Hess, et al.
International Journal of Oncology|July 6, 2007
Activation of polyamine catabolism by N1,N11-diethylnorspermine leads to cell death in glioblastomaRongcai Jiang, Woonyoung Choi, Asad Khan, et al.
British Journal of Cancer|September 2, 2020
Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trialsJohnique T Atkins, Goldy C George, Kenneth Hess, et al.
Breast Cancer Research and Treatment|July 16, 2009
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell linesCornelia Liedtke, Jing Wang, Attila Tordai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2017
Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern eraTodd A Pezzi, Chad Tang, Cameron W Swanick, et al.
The American Journal of Surgical Pathology|May 16, 2006
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomasHoward Colman, Caterina Giannini, Li Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer DrugsDiogo D G Bugano, Kenneth Hess, Denis L F Jardim, et al.
British Journal of Cancer|September 23, 2015
Clinical nomogram to predict bone-only metastasis in patients with early breast carcinomaYann Delpech, Sami I Bashour, Ruben Lousquy, et al.
Pageof 10